#CDXC

StockTitan

@stocktitan.net

1 year ago

Major Rebrand: ChromaDex Evolves to Niagen Bioscience, Sharpens Focus on Aging Science Leading NAD+ science company ChromaDex strategically rebrands as Niagen Bioscience, reinforcing its commitment to healthy aging research and innovation in longevity science.

#CDXC ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025

www.stocktitan.net/news/CDXC/chroma-dex-cor...

Small Cap Strategist

@smcapstrategist.bsky.social

1 year ago

Most searched small-cap stocks, Wed Mar 5th - #RIG #QGTS #WOLF #JBLU #APLD #CLSK #VRN #RXRX #CDXC #RIOT #BTE #IQ #BTG #CMRX #WULF #SMR #RGTI #GV #GRRR #BBAI - More: - crystalequityresearch.com/SmCpStr/ - #smallcap

StockTitan

@stocktitan.net

1 year ago

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results ChromaDex (NASDAQ:CDXC) reported strong financial results for Q4 and full year 2024. Fourth quarter highlights include net sales of $29.1 million (up 37% YoY), with Tru Niagen® sales of $22.7 million (up 29% YoY), and net income of $7.2 million.Full year 2024 performance showed total net sales of $99.6 million (up 19% YoY), gross margin of 61.8%, and net income of $8.6 million. The company generated $12.1 million in operating cash flows and ended the year with $44.7 million in cash and no debt.Key developments include the launch of Niagen Plus, a pharmaceutical-grade product line available at over 475 U.S. wellness clinics, and receiving FDA Orphan Drug and Rare Pediatric Disease Designations. For 2025, ChromaDex projects approximately 18% year-over-year revenue growth.

#CDXC ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2024 Results

www.stocktitan.net/news/CDXC/chroma-dex-cor...

Market Wire News

@marketwirenews.com

1 year ago

BREAKING NEWS: ( NASDAQ: #CDXC ) (CDXC) Investment Report

#StockMarket #News

StockTitan

@stocktitan.net

1 year ago

ChromaDex Named to Inc. 2024 Best in Business List for Health Products Innovation | CDXC Stock News ChromaDex earns prestigious Inc. recognition for its NAD+ research and Tru Niagen® products. Learn how their breakthrough aging solutions are reshaping the health supplement industry.

#CDXC ChromaDex Named to the Inc. 2024 Best in Business List in the Health Products Category

#news #investing #stocks

www.stocktitan.net/news/CDXC/chroma-dex-nam...

StockTitan

@stocktitan.net

1 year ago

#CDXC ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement

www.stocktitan.net/news/CDXC/chroma-dex-s-p...

InsiderFinance

@insiderfinance.com

1 year ago

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

PM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#GSAT, #CHPT, #ALIT, #CDXC, #AEHR

#OptionFlow #OptionsTrading #Trading

InsiderFinance

@insiderfinance.com

1 year ago

🚨 Institutions #optionsvolume surge detected!

PM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #GSAT 5.2x
2. #CHPT 4.9x
3. #ALIT 4.9x
4. #CDXC 3.9x
5. #BRBR 3.3x

#OptionFlow #OptionsTrading #Trading

Market Wire News

@marketwirenews.com

1 year ago

BREAKING NEWS: ( NASDAQ: #CDXC ) ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow Series On Thursday, August 29, 2024

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

BREAKING NEWS: ( NASDAQ: #CDXC ) ChromaDex to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

Just In: ( NASDAQ: #CDXC ) ChromaDex Appoints Carlos Lopez as Senior Vice President, General Counsel

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

JUST IN: ( NASDAQ: #CDXC ) ChromaDex Announces Pharmaceutical-Grade Intravenous and Injectable Niagen Will Debut at Leading Wellness Clinics in August

#StockMarket #News